The private-credit fear that cut the stock by nearly 40% is aimed at roughly a twentieth of the platform. At ~15x forward adjusted earnings after a brutal drawdown, the confirmation risk over the next several quarters sits with the bears. This is a high-quality compounder on s...
Read Article ›Amazon stock has slid back toward the low $240s even as AWS just posted its fastest growth in nearly four years. The bear case is simple and loud: capital spending has swallowed free cash flow. My argument is that this particular cash flow trough is the most defensible one Ama...
Read Article ›The market spent two years treating Comcast as a structurally challenged broadband utility with a fading media albatross stapled to it, and priced it accordingly. The separation of NBCUniversal and Sky directly attacks that framing by letting a cash-rich, under-cross-sold conn...
Read Article ›What the selloff underweights is that Microsoft has run this play before — it absorbed margin compression during the first Azure buildout and methodically clawed it back as utilization improved — and this time it holds more levers. The first is silicon. Its Cobalt CPU is now d...
Read Article ›The familiar standoff—elite CF monopoly versus a full multiple and a maturing core—resolves in the buyers' favor once you weight the catalysts by how knowable they are. CF is converting toward ALYFTREK on a long exclusivity runway and funding everything else; that is the demon...
Read Article ›This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
Read Article ›For most software companies past $5 billion in ARR, the law of large numbers grinds the growth rate of *incremental* bookings steadily lower. CrowdStrike did the opposite, and management leaned into it.
Read Article ›The central tension in Dexcom is whether its non-insulin type 2 expansion is a margin-accretive growth wave or a commoditization trap. The resolution is in the sequencing. The catalysts that drive the next several quarters — commercial coverage of all diabetics this summer, G7...
Read Article ›Duolingo is the rare consumer-software franchise that deliberately throttled its own near-term monetization to feed the top of its funnel — and the market has punished it as if the growth engine itself broke. The stock changes hands around **$123**, down roughly three-quarters...
Read Article ›The market is trading this as a comp-recovery story, and the comp has recovered, but the actual swing factor for the next leg of the stock is margin, and specifically North America margin, which is still badly depressed.
Read Article ›The market is pricing Match Group as a melting ice cube. The leading indicators say the ice has stopped melting — and the cash machine underneath is being badly underrated. Match Group is a portfolio of dating apps wrapped around two assets that matter and a long tail that mos...
Read Article ›Alphabet is three businesses wearing one ticker: an advertising machine (Search, YouTube, the Google Network) that still throws off the cash, a hyperscale cloud and AI infrastructure arm that has only recently become a real profit center, and a portfolio of long dated bets led...
Read Article ›Lumen is no longer the same company that frightened credit analysts two years ago. Strip away the legacy CenturyLink copper businesses and what remains is an enterprise and wholesale network operator built around three things: a 340,000 route mile fiber backbone, a fast growin...
Read Article ›The company is printing record revenue, expanding swaps share across every major currency, growing international past 40% of the mix, and converting more than $1 billion to free cash flow — yet the stock sits near a 52-week low because investors have fixated on a fee-per-milli...
Read Article ›Warner Bros Discovery offers a mid-to-high-teens gross return to a $31 cash takeout, backed by a buyer with unusually strong financial credibility–meanwhile the DOJ appears constructive; international approvals are accumulating; and the underlying business—particularly streami...
Read Article ›Intuit shares have been cut roughly in half from their 52-week high, recently trading in the low $300s, while Q3 fiscal 2026 revenue grew 10%, guidance was raised, and the highest-growth engines are compounding above 30%. TurboTax Live — Intuit's AI-plus-expert model — is on t...
Read Article ›Boston Scientific shares have been cut roughly in half since mid-2025, driven by a guidance cut, competitive headwinds in electrophysiology, softening WATCHMAN procedure volumes, and a Class I pacemaker recall. Yet the company still posted 9.4% organic growth in Q1 2026, is on...
Read Article ›McKesson delivered FY2026 adjusted EPS of $39.11 (+18% year-over-year), beating its own long-range growth targets, and guided FY2027 EPS to $43.80–$44.60 (+12–14%). Q4 revenue of $96.3 billion missed consensus by ~5%, but the miss reflects branded drug price deflation and GLP-...
Read Article ›Invitation Homes trades near $29, roughly 15% below the average sell-side target and at an implied cap rate approaching 7%—well above the low-4% cap rates the company is realizing on home dispositions to end buyers. That gap creates a rare capital-allocation opportunity that m...
Read Article ›TKO reported Q1 2026 revenue of $1.60 billion (+26% year-over-year) and Adjusted EBITDA of $550 million (+32%), with management reaffirming full-year guidance of $5.68–$5.78 billion in revenue and $2.24–$2.29 billion in Adjusted EBITDA. An $800 million accelerated share repurc...
Read Article ›